TMS for Early Alzheimer's Disease Pilot
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can help people with early Alzheimer's or mild cognitive impairment. It aims to see if the treatment is safe and effective for slowing memory decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild cognitive impairment or mild Alzheimer's disease.
- You have test results (like a PET scan or spinal tap) showing amyloid buildup in your brain.
- You've had a brain scan done before (MRI or CT).
- You score above 24 on a memory test (MMSE) and your stage is mild (CDR 0.5 to 1).
- You are between 40 and 90 years old.
- You are on a stable dose of Alzheimer's medications for at least one month and do not have seizures or metal implants that prevent an MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a non-invasive brain stimulation technique (TMS) to target the cerebellum in people with Alzheimer's disease. It aims to see if this treatment can improve symptoms and cognitive function.
This study tests whether a non-invasive brain stimulation treatment called TMS (transcranial magnetic stimulation) can help people with early Alzheimer's disease or related memory problems. It's a safe, gentle way to stimulate brain cells using magnetic pulses.
This trial is testing whether a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (using magnetic fields to activate brain cells), can help improve memory and thinking in people with Alzheimer's disease. It is a potential option for those looking to explore additional treatment approaches.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.
This study tests whether a noninvasive magnetic brain stimulation treatment can slow down cognitive decline in people with early Alzheimer's disease. You'll receive daily sessions over several weeks, and the goal is to see if it helps preserve memory and thinking skills.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.